|
Sign In to gain access to subscriptions and/or personal tools.
|
Muscarinic and Nicotinic Cholinergic Mechanisms in the Mesostriatal Dopamine Systems
Fu-Ming Zhou
Charles Wilson
John A. Dani
The striatum and its dense dopaminergic innervation originating in the midbrain, primarily from the substantia nigra pars compacta and the ventral tegmental area, compose the mesostriatal dopamine (DA) systems. The nigrostriatal system is involved mainly in motor coordination and in disorders such as Tourettes syndrome, Huntingtons disease, and Parkinsons disease. The dopaminergic projections from the ventral tegmental area to the striatum participate more in the processes that shape behaviors leading to reward, and addictive drugs act upon this mesolimbic system. The midbrain DA areas receive cholinergic innervation from the pedunculopontine tegmentum and the laterodorsal pontine tegmentum, whereas the striatum receives dense cholinergic innervation from local interneurons. The various neurons of the mesostriatal systems express multiple types of muscarinic and nicotinic acetylcholine receptors as well as DA receptors. Especially in the striatum, the dense mingling of dopaminergic and cholinergic constituents enables potent interactions. Evidence indicates that cholinergic and dopaminergic systems work together to produce the coordinated functioning of the striatum. Loss of that cooperative activity contributes to the dysfunction underlying Parkinsons disease.
Key Words: Acetylcholine Basal ganglia Dopamine Mesolimbic Nigrostriatal Nucleus accumbens Parkinsons disease Striatum Substantia nigra Ventral tegmental area
The Neuroscientist, Vol. 9, No. 1,
23-36 (2003)
DOI: 10.1177/1073858402239588

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. O. Tan and D. Bullock
A Dopamine-Acetylcholine Cascade: Simulating Learned and Lesion-Induced Behavior of Striatal Cholinergic Interneurons
J Neurophysiol,
October 1, 2008;
100(4):
2409 - 2421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Sullivan, H. Chen, and H. Morikawa
Recurrent Inhibitory Network among Striatal Cholinergic Interneurons
J. Neurosci.,
August 27, 2008;
28(35):
8682 - 8690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. V. Poisik, J.-x. Shen, S. Jones, and J. L. Yakel
Functional {alpha}7-containing nicotinic acetylcholine receptors localize to cell bodies and proximal dendrites in the rat substantia nigra pars reticulata
J. Physiol.,
March 1, 2008;
586(5):
1365 - 1378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cubo, K. M. Shannon, D. Tracy, J. A. Jaglin, B. A. Bernard, J. Wuu, and S. E. Leurgans
Effect of donepezil on motor and cognitive function in Huntington disease.
Neurology,
October 10, 2006;
67(7):
1268 - 1271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Perez-Rosello, A. Figueroa, H. Salgado, C. Vilchis, F. Tecuapetla, J. N. Guzman, E. Galarraga, and J. Bargas
Cholinergic Control of Firing Pattern and Neurotransmission in Rat Neostriatal Projection Neurons: Role of CaV2.1 and CaV2.2 Ca2+ Channels
J Neurophysiol,
May 1, 2005;
93(5):
2507 - 2519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Warren, M. A. Piggott, E. K. Perry, and D. J. Burn
Cholinergic systems in progressive supranuclear palsy
Brain,
February 1, 2005;
128(2):
239 - 249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhang, F.-M. Zhou, and J. A. Dani
Cholinergic Drugs for Alzheimer's Disease Enhance in Vitro Dopamine Release
Mol. Pharmacol.,
September 1, 2004;
66(3):
538 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|